{"slug":"api-magentlab-com-api-calc-carg-tt-1fe016","title":"Hurria 2011 Table 5 CARG toxicity","host":"api.magentlab.com","method":"POST","resource":"https://api.magentlab.com/api/calc/carg_tt","category":"other","description":"Hurria 2011 Table 5 CARG toxicity: age ≥72 (+2), GI/GU (+2, not inverted), standard dose (+2), polychemotherapy (+2), Hb male <11 or female <10 g/dL (+3), caller-assigned Jelliffe CrCl <34 (+3; magent does not compute Jelliffe), hearing fair/worse (+2), ≥1 fall in 6 months (+3), limited walking 1 bl","price_listed":0.005,"price_asked":0.007,"state":"overcharges","state_label":"Asked 1.4x its listed price for its own example","checks_7d":1,"answered_7d":1,"latency_ms_median":304,"reported_calls_30d":0,"reported_payers_30d":0,"networks":["eip155:8453"],"badge":"unverified","paid_checks_7d":0,"paid_ok_7d":0,"example_input":{"body":{"items":[{"age":75,"decreased_social_activity":false,"falls_last_6_months":false,"gi_or_gu":true,"hearing_fair_or_worse":false,"hemoglobin_g_dl":12,"jelliffe_crcl_ml_min":50,"limited_walking_one_block":false,"needs_help_with_medications":false,"polychemotherapy":true,"sex":"male","standard_dose":true},{"age":75,"decreased_social_activity":false,"falls_last_6_months":false,"gi_or_gu":true,"hearing_fair_or_worse":false,"hemoglobin_g_dl":12,"jelliffe_crcl_ml_min":50,"limited_walking_one_block":false,"needs_help_with_medications":false,"polychemotherapy":true,"sex":"male","standard_dose":true}]},"method":"POST","type":"http"},"output_schema":{"$schema":"https://json-schema.org/draft/2020-12/schema","properties":{"input":{"additionalProperties":false,"properties":{"body":{"additionalProperties":false,"properties":{"items":{"items":{"properties":{"age":{"description":"Age in years (18-120). Hurria 2011 Table 5: ≥72 scores 2. Derived in patients ≥65; magent still applies the ≥72 rule at any accepted age.","type":"integer"},"decreased_social_activity":{"description":"MOS decreased social activity limited at least sometimes as assigned by the caller (Hurria 2011 Table 5). true scores 1. magent does not administer MOS.","type":"boolean"},"falls_last_6_months":{"description":"≥1 fall in the last 6 months as assigned by the caller (Hurria 2011 Table 5). true scores 3. magent does not take a fall history.","type":"boolean"},"gi_or_gu":{"description":"GI or GU cancer as assigned by the caller (Hurria 2011 Table 5). true scores 2. Lung, breast, GYN, and other cancers are 0. This is a risk factor present (+2), not inverted. magent does not assign cancer type from histology text.","type":"boolean"},"hearing_fair_or_worse":{"description":"Hearing fair or worse as assigned by the caller (Hurria 2011 Table 5). true scores 2. magent does not examine hearing.","type":"boolean"},"hemoglobin_g_dl":{"description":"Hemoglobin in g/dL (3-22). Male <11 or female <10 scores 3 (Hurria 2011 Table 5). 11.0 male and 10.0 female do not score.","type":"number"},"jelliffe_crcl_ml_min":{"description":"Jelliffe ideal-weight creatinine clearance in mL/min as assigned by the caller (1-300). <34 scores 3 (Hurria 2011 Table 5). 34 does not score. magent does not compute Jelliffe.","type":"number"},"limited_walking_one_block":{"description":"MOS walking 1 block somewhat limited or limited a lot as assigned by the caller (Hurria 2011 Table 5). true scores 2. magent does not administer MOS.","type":"boolean"},"needs_help_with_medications":{"description":"IADL taking medications some help or unable as assigned by the caller (Hurria 2011 Table 5). true scores 1. magent does not administer IADL.","type":"boolean"},"polychemotherapy":{"description":"Polychemotherapy as assigned by the caller (Hurria 2011 Table 5). true scores 2.","type":"boolean"},"sex":{"description":"Sex used for the hemoglobin cutoff (female or male). Male <11 g/dL or female <10 g/dL scores 3.","enum":["female","male"],"type":"string"},"standard_dose":{"description":"Standard chemotherapy dose as assigned by the caller (Hurria 2011 Table 5). true scores 2. Dose-reduced is 0. magent does not read a chemo order.","type":"boolean"}},"required":["age","gi_or_gu","standard_dose","polychemotherapy","hemoglobin_g_dl","sex","jelliffe_crcl_ml_min","hearing_fair_or_worse","falls_last_6_months","limited_walking_one_block","needs_help_with_medications","decreased_social_activity"],"type":"object"},"maxItems":25,"minItems":1,"type":"array"}},"required":["items"],"type":"object"},"headers":{"additionalProperties":{"type":"string"},"type":"object"},"method":{"const":"POST","type":"string"},"type":{"const":"http","type":"string"}},"required":["type","method"],"type":"object"},"output":{"properties":{"example":{"type":"object"},"type":{"type":"string"}},"required":["type"],"type":"object"}},"required":["input"],"type":"object"},"history":[{"day":"2026-09-28","reachable":true,"status":402,"valid_402":true,"asked_usdc":0.007,"price_match":false,"latency_ms":304,"error":null}],"description_full":"Hurria 2011 Table 5 CARG toxicity: age ≥72 (+2), GI/GU (+2, not inverted), standard dose (+2), polychemotherapy (+2), Hb male <11 or female <10 g/dL (+3), caller-assigned Jelliffe CrCl <34 (+3; magent does not compute Jelliffe), hearing fair/worse (+2), ≥1 fall in 6 months (+3), limited walking 1 block (+2), help with meds (+1), decreased social activity (+1). Max 19. 0-5 low 30%, 6-9 intermediate 52%, 10-19 high 83%. Not the 2016 revision, not CRASH, not a chemo order.","last_updated":"2026-09-28T14:38:52.321Z","schemes":["exact"]}